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Abstract
Background: Published data regarding the associations between genetic variants and asthma risk in Chinese
population were inconclusive. The aim of this study was to investigate asthma susceptible genes in Chinese
population.
Methods: The authors conducted 18 meta-analyzes for 18 polymorphisms in 13 genes from eighty-two
publications.
Results: Seven polymorphisms were found being associated with risk of asthma, namely: A Disintegrin and
Metalloprotease 33 (ADAM33) T1-C/T (odds ratio [OR] = 6.07, 95% confidence interval [CI]: 2.69-13.73), Angiotensin-
Converting Enzyme (ACE) D/I (OR = 3.85, 95%CI: 2.49-5.94), High-affinity IgE receptor b chain (FcεRIb) -6843G/A
(OR = 1.49, 95%CI: 1.01-2.22), Interleukin 13(IL-13) -1923C/T (OR = 2.99, 95%CI: 2.12-4.24), IL-13 -2044A/G (OR = 1.49,
95%CI: 1.07-2.08), Regulated upon Activation, Normal T cell Expressed and Secreted (RANTES) -28C/G (OR = 1.64, 95%
CI: 1.09-2.46), Tumor Necrosis Factor-a (TNF-a) -308G/A(OR = 1.42, 95%CI: 1.09, 1.85). After subgroup analysis by age,
the ACE D/I, b2-Adrenergic Receptor (b2-AR) -79G/C, TNF-a -308G/A, Interleukin 4 receptor(IL-4R) -1902G/A and IL-13
-1923C/T polymorphisms were found significantly associated with asthma risk in Chinese children. In addition, the
ACE D/I, FcεRIb -6843G/A, TNF-a -308G/A, IL-13 -1923C/T and IL-13 -2044A/G polymorphisms were associated with
asthma risk in Chinese adults.
Conclusion: ADAM33, FcεRIb, RANTES, TNF-a, ACE, b2-AR, IL-4R and IL-13 genes could be proposed as asthma
susceptible genes in Chinese population. Given the limited number of studies, more data are required to validate
these associations.
Introduction
Asthma is one of the most common chronic respiratory
diseases, affecting about 300 millions of children and
adults worldwide[1]. In China, more than 25 millions
people are asthmatic patients, which includes almost
10 million children[2]. Compared with the western
world, the preventive controls and treatments for
asthma were not well established in China [3]. Only a
few percent of asthma patients received proper treat-
ment. Poverty and inadequate resources are the main
hindrance to reduce the burden of disease in China
especially in numerous of Chinese villagers. Therefore,
the best approach to reduce asthma is primary preven-
tion through modifying the risk factors of asthma.
It is well accepted that asthma is a complex disease
and both genetic and environmental factors contribute
to its inception and evolution[4,5]. Many studies regard-
ing associations between genetic variants and asthma
risk have been published and many genes were proposed
as asthma susceptible genes[6-9]. However, the conclu-
sions obtained from different populations were often dif-
ferent or even controversial. Possible roles may be that
different genetic backgrounds and environment expo-
sures in different ethnic population that may affect the
pathogenesis of asthma. Thus, asthma susceptible genes
in different population may not be the same.
In recent years, host genetic susceptibility to asthma
has been a research focus in scientific community in
China. Many genes were suggested as asthma risk
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studies drew incompatible or even contradictory results.
Considering a small number of sample size may be lack
of power to reveal the reliable conclusion, we carried
out a meta-analysis to assess the susceptible genes for
asthma in Chinese population. To our knowledge, this is
the first comprehensive and largest genetic meta-analysis
conducted in people of Chinese descent for any respira-
tory diseases.
Materials and methods
Literature search
We conducted a literature search by using the electronic
database Medline (Ovid), Pubmed, Embase, ScienceDir-
ect, Springer, CNKI, Wanfang database, Weipu database
and CBM database to identify articles that evaluated the
association between genetic variants and the risk of
asthma in Chinese population (Last search was updated
on May 13, 2010). The search terms were used as
follows: ‘asthma or asthmatic’, in combination with
‘polymorphism or variant or mutation’ and ‘Chinese or
China’ for Medline (Ovid), Pubmed, Embase, Science-
Direct, Springer database; ‘asthma or asthmatic’,i n
combination with ‘polymorphism or variant or mutation’
for CNKI database, Wanfang database, Weipu database
and CBM database. All languages were included. The
following criteria were used for selecting literatures in
the meta-analysis: (1) the study should evaluate the
association between genetic variants and risk of asthma
in Chinese population from either mainland, overseas or
both, (2) the study should be a case-control design pub-
lished in a journal (3) genotype distributions in both
cases and controls were available for estimating an odds
ratio with 95% confidence interval (CI) and P value, (4)
genotype distributions of control population must be
consistent with Hardy-Weinberg equilibrium(HWE), P >
0.05 (5) the polymorphism for data synthesis should be
studied in at least three case-control studies, (6) poly-
morphisms for data synthesis should be characterized as
-A/B, with the following genotypes: AA, AB and BB.
Accordingly, the following exclusion criteria were used:
(1) abstracts and reviews, (2)genotype frequency not
reported, (3) repeated or overlapping publications (4)
polymorphisms with data less than three case-control
studies (5) genotype distributions of control population
not consistent with HWE, (6)genetic variants not char-
acterized as -A/B. For duplication or overlapping publi-
cations, the studies with larger number of cases and
controls or been published latest were included.
Data extraction
Two independent authors (Xiaobo Li and Yonggang
Zhang) checked all potentially relevant studies and
reached a consensus on all items. In case of disagreement,
a third author(Jie Zhang) would assess these articles. The
following data were collected from each study: first author,
year of publication, location of the people, ages, genotype
frequencies in cases and controls.
Statistical Analysis
For each case-control study, we first examined whether
the genotype distribution in control group was accord-
ing to Hardy-Weinberg equilibrium by Pearson’s X
2 test
http://ihg2.helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl.
Any polymorphism that had been studied in at least
three case-control studies was included in the meta-ana-
lysis. The strength of the associations between asthma
risk and genetic variants were estimated by ORs and
95% CIs. The statistical significance of summary ORs
were assessed by Z-test. The evaluated genetic models
for each study were based mostly on those used in pri-
mary studies. Heterogeneity was evaluated by a X
2-based
Q statistic and was considered statistical significant at
P value < 0.10. I
2 was used to measure the percentage of
variability in point estimated that due to heterogeneity
rather than sampling error. When the P-value is > 0.10,
the pooled OR was calculated by the fixed-effects
model, otherwise, a random-effects model was used. To
evaluate the age-specific effects, subgroup analyses were
performed by age for polymorphisms which were inves-
tigated in a sufficient number of studies(data were avail-
able from at least three case-control studies for at least
one subgroup). Publication bias was examined by using
the funnel plots, Begg’s test and Egger’s test[4]. The fun-
nel plot is asymmetrical when there is evidence of publi-
cation bias. All statistical tests were performed by using
REVMAN 4.2 software and STATA 10.0.
Results
Candidate asthma-genes in Chinese Population
The selection process is shown in Figure 1. Briefly, 2489
search results were identified from Medline (Ovid),
Pubmed, Embase, ScienceDirect, Springer, CNKI data-
base, Wanfang database, Weipu database and CBM data-
base in the initial search. After reading the titles and
abstracts, 2159 articles were excluded for abstracts,
reviews, duplicated search results or not being relevant to
genetic variants and asthma risk in Chinese population.
By reading through the full texts of the remaining
330 articles, 7 articles were excluded for not being rele-
vant to polymorphisms and asthma risk. The remaining
323 articles were used for data extraction. A total of
539 case-control studies were extracted from 248 articles,
and 75 articles were excluded because of the absence of
the usable data or not a case-control design. In meta-ana-
lysis, a small number of studies weaken the conclusions;
therefore, only polymorphisms which had been investi-
gated in at least three case-control studies were included
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morphisms which were studied in less than three case-
control studies(a total of 260 case-control studies were
excluded). Hence, a total of 279 case-control studies were
left. In addition, genotype frequencies for control popula-
tion in 53 case-control studies were not consistent with
HWE and these case-control studies were all excluded. In
the remaining 226 case-control studies, data in 45 case-
control studies were overlapped or duplicated with other
studies and these case-control studies were all excluded.
Thus, 181 case-control studies were left. Among the 181
case-control studies, some polymorphisms were studied
in less than three case-control studies, and these poly-
morphisms were also excluded(a total of 62 case-control
studies were excluded). Finally, a total of 18 polymorph-
isms in 13 genes in 119 case-control studies concerning
genetic variants and asthma risk in Chinese population
met the inclusion criteria, were identified for data
synthesis (Table 1). The characteristics of each poly-
morphism are listed in Table 2, 3, 4, 5, 6, 7, 8, 9, 10, 11,
12, 13, 14, 15, 16, 17, 18 and 19. The genetic models for
pooling data are also listed in Table 1.
Summary results of Meta-analyzes
For each polymorphism, heterogeneity was analyzed by a
X
2-based Q statistic and was considered statistical signifi-
cant at P-value <0.10. When the P-value is less than 0.10,
the pooled OR of each meta-analysis was calculated by
the fixed-effects model; otherwise, a random-effects
model was used. The chosen models to synthesize the
data for each polymorphism can be seen in Table 20.
Forest plots of each polymorphism can be seen in
Figure 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
and 19. In summary, we abstained significant results for
seven polymorphisms: ADAM33 T1-C/T (OR = 6.07, 95%
CI: 2.69-13.73, Z = 4.33, P < 0.0001), ACE D/I(OR = 3.85,
Figure 1 Flow diagram of included/excluded studies.
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Gene Chromosome
location
of gene
Polymorphism Aminoacid
change
Genetic
model
Genotypes
Evaluated
Other
genotypes
Cases Controls
b2-AR 5q31-32 -46G/A Arg16Gly Recessive GG GA+AA 1796 1589
-79G/C Gln27Glu Recessive GG GC+CC 823 692
IL-4R 16p11.2-12.1 -1902G/A Q576R Dominant GG+GA AA 2308 1971
-223G/A Ile/Val Recessive GG GA+AA 1623 1304
IL-4 5q31 -589C/T Dominant CC+CT TT 1724 1656
TNF-a 6p21.1-21.3 -308A/G Dominant AA+AG GG 1428 1511
FcεRIb 11q13 -6843G/A Glu237Gly Dominant GG+GA AA 1434 1276
-109C/T Recessive CC CT+TT 428 371
ACE 17q23 D/I Recessive DD DI+II 385 335
IL-13 5q31 -2044A/G Gln130Arg Dominant AA+AG GG 1512 1351
-1923C/T Recessive TT CC+CT 645 588
IL-1b 2q12-21 -511C/T Dominant TT+TC CC 333 255
LT-a 6q21.3 +252A/G Dominant GG+GA AA 674 896
TGF-b1 19q13 -509C/T Dominant TT+TC CC 406 390
CD14 5q31.1 -159C/T Dominant TT+TC CC 1381 1219
ADAM33 20p13 T1 Met764Thr Recessive CC TT+TC 569 512
RANTES 17q11.2-12 -28G/C Dominant GG+GC CC 314 229
Table 2 Main data of all studies included in the meta-analysis for the -46G/A (Arg16Gly) polymorphism in b2-AR gene
Case Control
Study Population location Year Age AA AG GG AA AG GG OR 95%CI
Chan, I H [16] Hong Kong 2008 10.4 ± 3.7 101 135 59 51 89 33 1.06 0.66-1.70
Cui, LY(Han) [17] Neimenggu 2007 21-62 6 34 2 6 20 4 0.33 0.06-1.90
Cui, LY(Meng) [17] Neimenggu 2007 26-69 3 21 6 6 19 5 1.25 0.34-4.64
Gao, J M [18] Beijing 2004 38.7 ± 13.8 38 59 28 35 53 8 3.18 1.37-7.33
Li, H [19] Shanghai 2009 3-12 86 76 30 46 100 46 0.59 0.35-0.98
Liao, W [20] Chongqing 2001 5.8 ± 4.3 12 27 11 14 28 8 1.48 0.54-4.06
Qiu, Y Y(2008) [21] Jiangsu 2008 63.2 ± 5.6 25 31 14 34 55 23 0.97 0.46-2.04
Shi, X H [22] Jiangsu 2008 34(14-66) 22 19 7 10 25 13 0.46 0.17-1.28
Wang, Z [23] Anhui 2001 30.6 ± 16.2 52 54 22 38 64 34 0.62 0.34-1.14
Xie, Y [24] Shanghai 2008 4.98 ± 2.78 14 37 6 21 34 7 0.92 0.29-2.93
Xing, J [25] Beijing 2001 20-66 9 62 29 29 55 16 2.14 1.08-4.26
Zhang, X Y [26] Chongqing 2008 1.08-17 81 111 25 19 23 8 0.68 0.29-1.62
Wang, J Y [27] Taiwan 2009 7.82 ± 3.81 138 207 97 173 250 87 1.37 0.99-1.89
Table 3 Main data of all studies included in the meta-analysis for the -79G/C (Gln27Glu) polymorphism in b2-AR gene
Case Control
Study Population location Year Age CC CG GG CC CG GG OR 95%CI
Cui, LY(Han) [17] Neimenggu 2007 21-62 32 6 4 26 3 1 3.05 0.32-28.79
Gao, G K [28] Beijing 2002 4-56 20 32 6 32 49 8 1.17 0.38-3.56
Liao, W [20] Chongqing 2001 5.8 ± 4.3 26 20 4 20 27 3 1.36 0.29-6.43
Lin, Y C [29] Taiwan 2003 13.9 ± 0.07 65 15 0 54 14 1 0.28 0.01-7.08
Pan, Y P [30] Jiangxi 2005 - 15 24 6 17 23 5 1.23 0.35-4.37
Qiu, Y Y(2000) [31] Jiangsu 2000 42 ± 5 23 30 6 29 36 7 1.05 0.33-3.32
Qiu, Y Y(2008) [21] Jiangsu 2008 63.2 ± 5.6 56 13 1 90 20 2 0.80 0.07-8.96
Wang, Z [23] Anhui 2001 30.6 ± 16.2 108 19 1 113 22 1 1.06 0.07-17.18
Ye, X W [32] Guizhou 2003 42.68 ± 10.55 25 39 10 15 20 4 1.37 0.40-4.68
Zhang, X Y [26] Chongqing 2008 1.08-17 54 119 44 8 24 18 0.45 0.23-0.88
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Page 4 of 2195%CI: 2.49-5.94, Z =6 . 0 7 ,P < 0.00001), FcεRIb -6843G/A
(OR = 1.49, 95%CI: 1.01-2.22, Z =1 . 9 9 ,P =0 . 0 5 ) ,IL-13
-1923C/T(OR = 2.99, 95%CI: 2.12-4.24, Z = 6.19,
P< 0.00001), IL-13 -2044A/G(OR = 1.49, 95%CI: 1.07-2.08,
Z = 2.34, P =0 . 0 2 ) ,RANTES -28C/G (OR = 1.64, 95%CI:
1.09-2.46, Z =2 . 3 6 ,P = 0.02), TNF-a -308G/A (OR =
1.42, 95%CI: 1.09-1.85, Z = 2.63, P = 0.009). These results
indicated that these polymorphisms were significant asso-
ciated with asthma risk in Chinese population. All results
for all 18 meta-analyzes are summarized in table 20.
To evaluate the age-specific effects, subgroup analyses
were performed by age for polymorphisms which were
investigated in a sufficient number of studies(data were
available from at least three case-control studies for at
least one subgroup). Three subgroups were used: adults,
children, others(ages in these case-control studies were
not mentioned or mixed with adults and children).
Briefly, we obtained significant results from five poly-
morphisms(ACE D/I, b2-AR -79G/C, TNF-a -308G/A,
IL-4R -1902G/A and IL-13 -1923C/T) in children and
Table 4 Main data of all studies included in the meta-analysis for the -1902G/A (Q576R) polymorphism in IL-4R gene
Case Control
Study Population location Year Age AA AG GG AA AG GG OR 95%CI
Cui, T P[33] Hubei 2003 3-68 129 89 23 130 41 4 2.51 1.64-3.83
Deng, R Q[34] Guangdong 2006 8-75 26 42 32 15 38 47 0.50 0.25-1.02
Gui, Q[35] Chongqing 2006 49(28-72) 33 15 2 34 14 2 1.09 0.48-2.52
Hu, S Y[36] Guangdong 2005 2-16 90 66 19 130 41 4 2.73 1.74-4.28
Liu, L N[37] Henan 2005 3-15 46 27 3 47 12 1 2.36 1.09-5.08
Mak, J C[38] Hong Kong 2007 42.4 ± 16.1 200 81 4 191 91 9 0.81 0.57-1.15
Sun, J[39] Heilongjiang 2010 3-14 67 24 0 33 9 0 1.31 0.55-3.14
Wu, X H[40] Hubei 2010 8.8 183 61 8 168 55 4 1.07 0.72-1.61
Zhang, A M[41] Hunan 2005 3-14 55 39 0 57 11 0 3.67 1.71-7.89
Zhang, H[42] Shanghai 2007 - 257 87 8 87 27 0 1.19 0.73-1.95
Zhang, W[43] Singapore 2007 - 115 30 0 115 38 4 0.71 0.42-1.22
Wang, J Y[27] Taiwan 2009 7.82 ± 3.81 326 112 9 360 140 12 0.88 0.66-1.17
Table 5 Main data of all studies included in the meta-analysis for the -223G/A (Ile/Val) polymorphism in IL-4R gene
Case Control
Study Population location Year Age AA AG GG AA AG GG OR 95%CI
Chan, I H [16] Hong Kong 2008 10.4 ± 3.7 79 159 57 49 80 38 0.81 0.51-1.29
Deng, R Q[44] Guangdong 2006 8-75 24 47 29 9 33 58 0.30 0.16-0.53
Yang, Q[45] Jiangxi 2004 18-71 6 21 7 8 16 5 1.24 0.35-4.44
Zhang, H[42] Shanghai 2007 - 106 168 78 44 53 17 1.62 0.92-2.88
Zhang, W[43] Singapore 2007 - 32 84 29 42 76 39 0.76 0.44-1.30
Wang, J Y[27] Taiwan 2009 7.82 ± 3.81 105 201 139 124 250 136 1.25 0.94-1.65
Wu, X H[40] Hubei 2010 8.8 46 131 75 59 110 58 1.23 0.83-1.85
Table 6 Main data of all studies included in the meta-analysis for the -589 C/T polymorphism in IL-4 gene
Case Control
Study Population location Year Age TT CT CC TT CT CC OR 95%CI
Cui, T P[33] Hubei 2003 3-68 141 89 11 114 52 9 1.33 0.89-1.98
Hu, S Y[36] Guangdong 2005 2-16 108 59 8 114 52 9 1.16 0.75-1.79
Liu, L N[37] Henan 2005 3-15 45 29 2 34 23 3 0.90 0.45-1.79
Mak, J C[38] Hong Kong 2007 42.4 ± 16.1 179 95 15 186 87 19 1.08 0.77-1.51
Wang, W[46] Xinjiang 2004 39 ± 8 22 42 29 15 26 21 1.03 0.49-2.19
Wu, X H[40] Hubei 2010 8.8 163 83 6 132 84 11 0.76 0.52-1.10
Zhang, W D[47] Singapore 2005 - 101 47 4 109 45 3 1.15 0.71-1.85
Wang, J Y[27] Taiwan 2009 7.82 ± 3.81 279 145 22 309 183 16 0.93 0.72-1.21
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Case Control
Study Population location Year Age GG GA AA GG GA AA OR 95%CI
Gao, J M[48] Beijing 2003 38.7 ± 13.8 47 52 26 44 41 11 1.40 0.82-2.41
Guo, Y L[49] Jiangxi 2004 - 4 28 16 7 11 3 5.50 1.40-21.60
Li, Z F[50] Guangdong 2003 2-12 9 16 5 14 10 2 2.72 0.91-8.16
Liu, R M[51] Hubei 2004 2-15 98 15 0 104 22 0 0.72 0.36-1.47
Mak, J C[38] Hong Kong 2007 42.4 ± 16.1 244 47 1 250 40 2 1.17 0.75-1.84
Tan, E C[52] Singapore 1999 - 49 18 0 115 36 0 1.17 0.61-2.26
Wang, T N[53] Taiwan 2004 5-18 140 49 2 111 18 0 2.25 1.24-4.06
Zhai, F Z[54] Shandong 2004 35.80 ± 10.18 44 14 6 67 12 1 2.34 1.06-5.19
Zhao, H J[55] Jilin 2005 - 45 5 0 71 9 0 0.88 0.28-2.78
Wang, J Y[27] Taiwan 2009 7.82 ± 3.81 345 100 3 409 94 7 1.21 0.89-1.65
Table 8 Main data of all studies included in the meta-analysis for the -6843G/A polymorphism in FcεRI b gene
Case Control
Study Population location Year Age AA AG GG AA AG GG OR 95%CI
Chan, I H[16] Hong Kong 2008 10.4 ± 3.7 267 23 1 154 13 0 1.06 0.53-2.15
Cui, T P[56] Hubei 2004 40.37 ± 15.09 60 40 6 78 26 2 2.14 1.20-3.81
Liu, T[57] Shandong 2006 36.5 45 14 1 39 10 1 1.18 0.49-2.87
Tang, Y[58] Guangdong 2003 39.5(12-67) 49 11 0 61 4 0 3.42 1.03-11.42
Wang, L[59] Hubei 2003 2-16 65 40 5 70 20 2 2.20 1.20-4.06
Zeng, L X[60] Jiangxi 2001 37(14-63) 61 5 3 27 1 0 3.54 0.42-29.73
Zhang, X Z[61] Singapore 2004 52 ± 16 81 57 3 108 42 7 1.63 1.02-2.62
Zhao, K S[62] Jilin 2004 1.5-14 126 23 2 92 13 0 1.40 0.68-2.89
Wang, J Y[27] Taiwan 2009 7.82 ± 3.81 309 121 16 314 165 27 0.73 0.55-0.95
Table 9 Main data of all studies included in the meta-analysis for the -109C/T polymorphism in FcεRI b gene
Case Control
Study Population location Year Age TT TC CC TT CT CC OR 95%CI
Li, H[19] Shanghai 2009 3-12 110 58 24 78 90 24 1.00 0.55-1.83
Wang, L[59] Hubei 2003 2-16 43 54 13 35 46 11 0.99 0.42-2.32
Zhao, K S [63] Jilin 2004 5.6 ± 3.1 46 69 11 40 38 9 0.83 0.33-2.09
Table 10 Main data of all studies included in the meta-analysis for the D/I polymorphism in ACE gene
Case Control
Study Population location Year Age(year) II DI DD II DI DD OR 95%CI
Gao, J M[64] Beijing 1999 39(16-69) 12 15 23 16 26 8 4.47 1.75-11.43
Guo, Y B[65] Guangdong 2006 0.33-3 27 18 7 36 32 4 2.64 0.73-9.56
Lu, H M[66] Tianjin 2004 37(18-52) 3 4 11 5 7 3 6.29 1.29-30.54
Lue, K H[67] Taiwan 2006 9.91 ± 1.62 48 40 17 56 42 4 4.73 1.53-14.60
Qin, J H[68] Liaoning 2000 6.9 ± 2.7 24 10 18 21 14 5 3.71 1.24-11.10
Song, L J[69] Jilin 2001 1-14 22 45 41 18 29 9 3.20 1.42-7.20
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Case Control
Study Population location Year Age GG AG AA GG AG AA OR 95%CI
Chan, I H[16] Hong Kong 2008 10.4 ± 3.7 94 136 43 54 70 17 1.18 0.78-1.80
Feng, D[70] Heilongjiang 2009 3-16 17 18 10 30 10 3 3.80 1.57-9.23
Liu, J L[71] Guangdong 2004 14-67 27 54 19 44 46 10 2.12 1.17-3.84
Wu, X H[40] Hubei 2010 8.8 105 111 36 125 84 18 1.72 1.19-2.46
Yang, L F[72] Gansu 2010 8 ± 4 71 60 47 73 66 19 1.29 0.84-2.00
Zhao, K S[73] Jilin 2005 1.5-14 18 60 52 8 42 50 0.54 0.23-1.30
Wang, J Y[27] Taiwan 2009 7.82 ± 3.81 203 194 49 212 234 59 0.87 0.67-1.12
Xi, D[74] Hubei 2004 ≥20 15 24 6 23 20 3 2.08 1.28-3.38
Xi, D[74] Hubei 2004 ≥4 10 25 8 16 13 2 3.52 1.30-9.55
Table 12 Main data of all studies included in the meta-analysis for the -1923C/T polymorphism in IL-13 gene
Case Control
Study Population location Year Age CC CT TT CC CT TT OR 95%CI
Song, Q Z[75] Guangdong 2005 14-67 24 55 21 43 47 10 2.39 1.06-5.39
Shi, X H[22] Jiangsu 2008 34(14-66) 12 26 10 30 16 2 6.05 1.25-29.32
Chen, J Q[76] Jiangsu 2004 2.59 ± 1.45 41 43 12 39 14 0 15.83 0.92-272.92
Wang, X H[77] Shandong 2009 39 ± 11 31 57 61 66 68 26 3.57 2.10-6.08
Wu, X H[40] Hubei 2010 8.8 106 114 32 126 85 16 1.92 1.02-3.60
Table 13 Main data of all studies included in the meta-analysis for the -511C/T polymorphism in IL-1b gene
Case Control
Study Population location Year Age GG GA AA GG GA AA OR 95%CI
Hsieh, C C[78] Taiwan 2004 8.74 ± 4.09 69 93 40 48 70 26 0.96 0.61-1.52
Wu, Z F[79] Jiangxi 2007 11-68 16 36 24 26 38 12 1.95 0.94-4.03
Zhao, X F[80] Yunnan 2006 5.9(3-14) 51 4 0 30 5 0 0.47 0.12-1.89
Table 14 Main data of all studies included in the meta-analysis for the +252A/G polymorphism in LT-a gene
Case Control
Study Population location Year Age AA AG GG AA AG GG OR 95%CI
Gao, J M[81] Beijing 2003 38.7 ± 13.8 13 63 49 14 46 36 1.47 0.66-3.30
Ma, W C[82] Guangdong 2005 1.8-9 8 14 10 26 46 28 1.05 0.42-2.64
Mak, J C[38] Hong Kong 2007 42.4 ± 16.1 70 146 69 79 134 76 1.16 0.80-1.68
Tan, E C[52] Singapore 1999 - 13 38 15 30 84 39 0.99 0.48-2.06
Xu, X[83] Guangdong 2003 18-69 12 21 19 26 47 30 1.13 0.51-2.46
Huang, S C[84] Taiwan 2008 9.9 ± 4.1 20 69 25 45 69 41 1.62 0.98-2.66
Table 15 Main data of all studies included in the meta-analysis for the -509C/T polymorphism in TGF-b1 gene
Case Control
Study Population location Year Age CC CT TT CC CT TT OR 95%CI
Lu, J R[85] Jilin 2004 1-13 45 38 15 30 19 3 1.61 0.81-3.17
Mak, J C[86] Hong Kong 2006 41.0 ± 16.1 46 109 93 51 155 102 0.87 0.56-1.35
Xia, W[87] Jiangxi 2006 15-60 22 26 12 17 11 2 2.26 0.92-5.52
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Case Control
Study Population location Year Age CC CT TT CC CT TT OR 95%CI
Chan, I H[16] Hong Kong 2008 10.4 ± 3.7 55 134 80 26 77 38 0.88 0.52-1.48
Chen, M[88] Guangdong 2009 14-71 63 62 25 40 68 42 0.50 0.31-0.82
Cui, T P[89] Hubei 2003 2-16 27 67 49 10 42 20 0.69 0.32-1.52
Tan, C Y[90] Taiwan 2006 - 17 56 47 24 55 41 1.51 0.77-2.99
Wu, X H[40] Hubei 2010 8.8 54 117 81 31 121 75 0.58 0.36-0.94
Wang, J Y[27] Taiwan 2009 7.82 ± 3.81 160 230 57 177 236 96 0.96 0.73-1.25
Table 17 Main data of all studies included in the meta-analysis for the T1-C/T polymorphism in ADAM33 gene
Case Control
Study Population location Year Age TT TC CC TT TC CC OR 95%CI
Su, D J[91] Heilongjiang 2008 36.69 ± 11.53 63 78 40 117 29 5 8.28 3.18-21.59
Wang, P[92] Shandong 2006 43.32 250 45 1 236 33 1 0.91 0.06-14.65
Xiong, J Y[93] Guangdong 2009 6-13 71 19 2 80 10 1 2.00 0.18-22.45
Table 18 Main data of all studies included in the meta-analysis for the -28G/C polymorphism in RANTES gene
Case Control
Study Population location Year Age CC CG GG CC CG GG OR 95%CI
Liu, M[94] Yunnan 2005 7.2 ± 4.8 25 6 1 29 3 0 2.71 0.63-11.59
Wang, L J[95] Hubei 2004 9 ± 3 65 31 4 72 17 1 2.15 1.11-4.17
Yao, T C[96] Taiwan 2003 - 134 39 9 83 23 1 1.24 0.71-2.17
Table 19 Main data of all studies included in the meta-analysis for the -403A/G polymorphism in RANTES gene
Case Control
Study Population location Year Age GG GA AA GG GA AA OR 95%CI
Leung, T F[97] Hongkong 2005 9.9 ± 3.4 60 53 16 37 21 8 1.47 0.81-2.66
Liu, M[94] Yunnan 2005 7.2 ± 4.8 17 13 2 16 14 2 0.88 0.33-2.35
Yao, T C[96] Taiwan 2003 - 98 65 19 60 41 6 1.09 0.68-1.77
Table 20 Summary results of the meta-analysis and publications bias
Pubilication bias (Begg’s test)
Gene Polymorphism Genotype investigated Studies Number Effect Model OR(95%CI) t P
b2-AR -46G/A GG 13 Random 1.02(0.75, 1.38) -0.66 0.525
-79G/C GG 10 Fixed 0.86(0.58, 1.29) 1.60 0.148
IL-4R -1902G/A GG+GA 12 Random 1.30(0.94, 1.80) 0.92 0.377
-223G/A GG 7 Random 0.92(0.63, 1.35) -0.81 0.453
IL-4 -589C/T CC+CT 8 Fixed 1.01(0.88, 1.16) 0.53 0.615
TNF-a -308A/G AA+AG 10 Random 1.42(1.09, 1.85) 1.38 0.205
FcεRIb -6843G/A GG+GA 9 Random 1.49(1.01, 2.22) 2.82 0.026
-109C/T CC 3 Fixed 0.96(0.62, 1.48) -1.10 0.471
ACE D/I DD 6 Fixed 3.85(2.49, 5.94) 0.88 0.429
IL-13 -2044A/G AA+AG 9 Random 1.49(1.07, 2.08) 1.93 0.095
-1923C/T TT 5 Fixed 2.99(2.12, 4.24) 1.19 0.320
IL-1b -511C/T TT+TC 3 Fixed 1.10(0.76, 1.59_ -0.16 0.896
LT-a +252A/G GG+GA 6 Fixed 1.26(0.98, 1.62) -0.02 0.985
TGF-b1 -509C/T TT+TC 3 Fixed 1.17(0.83, 1.64) 8.57 0.074
CD14 -159C/T TT+TC 6 Random 0.79(0.59, 1.06) -0.41 0.700
ADAM33 T1-C/T CC 3 Fixed 6.07(2.69, 13.73) -8.22 0.077
RANTES -28G/C GG+GC 3 Fixed 1.64(1.09, 2.46) 0.87 0.544
-403A/G AA+AG 3 Fixed 1.18(0.83, 1.67) -0.37 0.777
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Page 8 of 21Figure 2 Forest plot of asthma risk associated with b2-AR -46G/A in Chinese population. Subgroup analysis by age.
Figure 3 Forest plot of asthma risk associated with b2-AR -79G/C in Chinese population. Subgroup analysis by age.
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Page 9 of 21Figure 4 Forest plot of asthma risk associated with IL-4R -1902G/A in Chinese population. Subgroup analysis by age.
Figure 5 Forest plot of asthma risk associated with IL-4R -223G/A in Chinese population.
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Page 10 of 21Figure 6 Forest plot of asthma risk associated with IL-4 -589C/T in Chinese population. Subgroup analysis by age.
Figure 7 Forest plot of asthma risk associated with TNF-a -308A/G in Chinese population. Subgroup analysis by age.
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Page 11 of 21five polymorphisms(ACE D/I, FcεRIb -6843G/A, TNF-a
-308G/A, IL-13 -1923C/T, IL-13 -2044A/G) in adults.
Publication bias
The Begg’sf u n n e lp l o t sa n dE g g e r ’st e s t sw e r ep e r -
formed to assess the potential publication bias (Begg’s
funnel plots can be seen in Additional File 1). The
results did not suggest evidence of publication bias
except for the FcεRIb -6843G/A polymorphism. Statisti-
cal results of Begg’s test are summarized in Table 20.
Discussion
The aim of meta-analysis is to combine results from stu-
dies on the same topic and to produce more precise
results. The current study is to reveal the roles of
genetic variants and their associations with risk of
asthma in Chinese population. In summary, we finally
identified 18 polymorphisms in 13 genes. Among them,
seven polymorphisms (ADAM33 T1-C/T, ACE D/I,
FcεRIb -6843G/A, IL-13 -1923C/T, IL-13 -2044A/G,
RANTES -28C/G and TNF-a -308G/A) were statistically
associated with increased risk of asthma. In order to
analysis the age-specific associations, subgroup analysis
were performed by age. The ACE D/I, b2-AR -79G/C,
TNF-a -308G/A, IL-4R -1902G/A and IL-13 -1923C/T
polymorphisms were found being associated with
asthma risk in Chinese children, while the ACE D/I,
FcεRIb -6843G/A, TNF-a -308G/A, IL-13 -1923C/T,
IL-13 -2044A/G polymorphisms were associated with
asthma risk in Chinese adults. Given that the data
Figure 8 Forest plot of asthma risk associated with FcεRIb -6843G/A in Chinese population. Subgroup analysis by age.
Figure 9 Forest plot of asthma risk associated with FcεRIb -109C/T in Chinese population.
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control studies, the obtained results could be more pre-
cise than results obtained form any individual study.
The b2-AR gene is a critical gene in the pathogenesis
of asthma. b2-ARs are present on many airway
cells, especially in smooth muscle cells which are
hyperreactive in asthmatic patients. At present, b2-AR
agonists were major methods for treating asthmatic
patients. In this meta-analysis, ten case-control studies
for b2-AR -79G/C and eleven for -46G/A polymorph-
ism were identified. The results indicated the two poly-
morphisms were not associated with asthma risk in
Figure 10 Forest plot of asthma risk associated with ACE D/I in Chinese population. Subgroup analysis by age.
Figure 11 Forest plot of asthma risk associated with IL-13 -2044A/G in Chinese population. Subgroup analysis by age.
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Page 13 of 21Chinese population. After subgroup analysis by age,
the -79G/C polymorphism was associated with
decreased risk of asthma in Chinese children. Up to
now, three meta-analyses had been performed to inves-
tigate the association between polymorphism of b2-AR
gene and risk of asthma [10-12]. Thakkinstian A[12]
found that the heterozygote in -79G/C was associated
with decreased risk of asthma in both adults and chil-
dren. However, we didn’t find these associations in
Chinese adults, which suggested different roles of this
polymorphism may exist in the pathogenesis of asthma
in difference age groups. Previous study indicated that
the -46G allele enhanced agonist-induced down
regulation of the receptor, and the -79G allele might
enhance resistance to down regulation. In combination
with our results, personalized therapy of asthma
patients in different age population with different
genetic backgrounds in Chinese population should also
be carried out in clinical practices.
The TNF-a gene, encodes a key proinflammatory
cytokine in airway, is located on an asthma susceptible
region-chromosome 6p. The TNF-a protein plays a cen-
tral role in inflammation and involves in pathogenesis of
asthma. Several polymorphisms have been identified in
this gene, such as -308A/G, -238A/G. The -308A/G
polymorphism in the promoter may affect the
Figure 12 Forest plot of asthma risk associated with IL-13 -1923C/T in Chinese population.
Figure 13 Forest plot of asthma risk associated with IL-1b-511C/T in Chinese population.
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Page 14 of 21expression of this cytokine, which may affect the occur-
rence of asthma. In the meta-analysis performed by Gao
and colleagues[13], they found the A allele was signifi-
cant with increased risk of asthma (OR = 1.37, 95%CI =
1.02-1.84 for A vs. G). Consistently, we found the TNF-
a-308A/G polymorphism was significantly associated
with increased risk of asthma (OR = 1.36, 95%CT =
1.13-1.63 for AA+AG vs. GG) in Chinese population.
For A vs G, the pooled OR is 1.26 with 95%CI: 1.08-
1.47 in this study, which suggested a weaker association
between this polymorphism and asthma risk in Chinese
population.
IL-4 gene is located on chromosome 5q31, it was sug-
gested to be associated with asthma risk, including ele-
vated serum IgE levels and airway hypersensitiveness.
A few studies indicated the -589C/T polymorphism in
the promoter as a risk factor for asthma, but with
inconclusive results. Li and colleagues performed a
meta-analysis and found the T allele was associated with
decrease risk of asthma(T vs C: OR = 0.86, 95%CI =
0.78-0.94)[14]. However, our results didn’t reveal a posi-
tive association between this polymorphism and risk of
asthma in Chinese. Compared with Li’s study, the total
number of studies concerning the Chinese population
Figure 14 Forest plot of asthma risk associated with LT-a +252A/G in Chinese population.
Figure 15 Forest plot of asthma risk associated with TGF-b1 -509C/T in Chinese population.
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Page 15 of 21Figure 16 Forest plot of asthma risk associated with CD14 -159C/T in Chinese population.
Figure 17 Forest plot of asthma risk associated with ADAM33 T1-C/T in Chinese population.
Figure 18 Forest plot of asthma risk associated with RANTES -28G/C in Chinese population.
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Page 16 of 21was smaller, which suggested more studies should be
carried out to reveal these associations.
IL-4 and IL-13 signal through binding to a receptor
complex comprised of the IL-13Ra1a n dI L - 4 R a with
subsequent phosphorylation of JAKs and STAT6[15]. IL-
4 receptor plays its role in inflammation through IL-4
and IL-13. The IL-4 receptor gene is located on chromo-
some 16 p12.1-p11.2. Some polymorphisms had been
identified as risk factors for asthma, such as -1902G/A
and -223G/A. Our results indicated the -1902G/A poly-
morphism was associated with increased risk of asthma
in Chinese children, but not in Chinese adults. The
results also indicated the -223G/A polymorphism was
not associated with risk of asthma in Chinese population.
The FcεRIb gene is a major candidate gene, involving
in the pathogenesis of asthma. It is located on the chromo-
some 11q13. The -6843G/A polymorphism, leading change
in an amino acid sequence at residue 237 from glutamic
acid to glycine, is associated with increased IgE levels in
atopic asthmatic children. In Chinese population, the
-6843G/A polymorphism is the most extensively studied
polymorphism in FcεRIb gene. Our study revealed this
polymorphism as a risk factor of asthma in Chinese popu-
lation. Chinese who carry the GG or GA genotype have an
49% increased risk of asthma than AA carriers. Our results
also demonstrated the -109C/T polymorphism in this gene
was not associated with increased risk of asthma in
Chinese population.
Up to date, we first found that ADAM33 T1-C/T,
ACE D/I, IL-13 -1923C/T, RANTES -28C/G and IL-13
-2044A/G polymorphisms were associated with risk of
asthma in Chinese population by using meta-analyzes.
Some results are similar to other studies performed in
other ethnic- groups and some are not. In future, more
published results should be included to update and
validate these associations in Chinese population.
In this study, the rigorous inclusive criteria made the
results more precise. Any study in which genotype distri-
bution of control group divorced from HWE was
excluded. In this meta-analysis, 11 polymorphisms were
synthesized by using the fixed-effect model, 7 used ran-
dom-effects model. Because the fixed-effect model is more
precise than random effect model, the strength of evidence
of ADAM33 T1-C/T, ACE D/I, IL-13 -1923C/T, RANTES
-28C/G, as risk factors for asthma was greater than that of
FcεRIb -6843G/A, IL-13 -2044A/G and TNF-a -308G/A.
The heterogeneity of clinical information among
studies should also be mentioned. Heterogeneity is an
important issue when interpreting the results of meta-
analysis. Significant heterogeneity existed in overall
comparisons in a few meta-analyses, such as FcεRIb
-6843G/A. After subgroup analyses by age, the heteroge-
neity was effectively decreased or removed in adults.
Possible explanation may be that differences in etiology
may exist in difference age groups. Another important
factor contributing to heterogeneity was that homogene-
ity in either the case and control groups was uncertain.
Ideally, all cases and controls in this meta-analysis
should be matched for age, sex, atopic status and envir-
onmental exposures. However, these issues could not all
be explained precisely because of insufficient clinical
information for individual person. In addition, because
this study is based on population of Chinese descent
with the same genetic background, so the similarity of
these studies might be very good, despite most studies
were conducted in different areas of China.
Some limitations of this meta-analysis should be
acknowledged when explaining our results. First, only
published articles in the selected electronic databases
were included in this study, it may be possible that
some studies were not included in those databases or
some unpublished studies which had null results, which
might bias the results. Second, due to lack of sufficient
data, the homogeneity in either the case and control
groups was uncertain and data were not stratified by
other factors such as atopic status or sex. The tests for
gene-environment interactions were not carried out
either. Third, publication bias may affect the results.
Figure 19 Forest plot of asthma risk associated with RANTES -403A/G in Chinese population.
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Page 17 of 21Although P values of Begg’s test were more than 0.05 in
18 meta-analyses, we could not rule out this possibility,
because for some polymorphisms, the included number
of studies were relatively small. Third, this study didn’t
included some polymorphisms with lack of number of
studies, or polymorphisms which were not characterized
as -A/B for lack of quality analysis for HWE, some poly-
morphism, such as GSTM1-P/N, or HLA DR1 alleles
and MHC alleles were not included, future studies
should performed to analysis the effect of these poly-
morphism in Chinese population.
T oo u rk n o w l e d g e ,t h i si st h ef i r s ta n dm o s tc o m p r e -
hensive genetic meta-analysis to date conducted in Chi-
nese descent for any respiratory diseases. In conclusion,
this meta-analysis indicated the T1-C/T polymorphism
in ADAM33 gene, the D/I polymorphism in ACE gene,
the -6843G/A polymorphism in FcεRIb gene, the
-1923C/T polymorphism in IL-13 gene, the -2044A/G
polymorphism in IL-13 gene, the -28C/G polymorphism
in RANTES gene and the -308G/A polymorphism in
TNF-a gene are associated with asthma risk in Chinese
population. And these results may also implicate in per-
sonalized therapy for asthma in Chinese population. In
future, more studies should be conducted to investigate
the gene-gene and gene-environment interactions
between these polymorphisms in Chinese population.
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Additional file 1: Begg’s funnel plots for publication bias in
selection of studies on asthma susceptibility genes in Chinese.
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Figure S14 Begg’s funnel plots for publication bias in selection of studies
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